135 related articles for article (PubMed ID: 30640960)
1. Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
PLoS One; 2019; 14(1):e0210929. PubMed ID: 30640960
[TBL] [Abstract][Full Text] [Related]
2. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
[TBL] [Abstract][Full Text] [Related]
3. Correction: Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
Waite RD; Qureshi MR; Whiley RA
PLoS One; 2017; 12(4):e0176577. PubMed ID: 28426833
[TBL] [Abstract][Full Text] [Related]
4. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
[TBL] [Abstract][Full Text] [Related]
5. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient.
Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D
J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.
Marvig RL; Sommer LM; Jelsbak L; Molin S; Johansen HK
Future Microbiol; 2015; 10(4):599-611. PubMed ID: 25865196
[TBL] [Abstract][Full Text] [Related]
8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
9. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
10. Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.
Marvig RL; Dolce D; Sommer LM; Petersen B; Ciofu O; Campana S; Molin S; Taccetti G; Johansen HK
BMC Microbiol; 2015 Oct; 15():218. PubMed ID: 26482905
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
[TBL] [Abstract][Full Text] [Related]
14. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
Ojeniyi B
APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
Smith DJ; Ramsay KA; Yerkovich ST; Reid DW; Wainwright CE; Grimwood K; Bell SC; Kidd TJ
Respirology; 2016 Feb; 21(2):329-37. PubMed ID: 26711802
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
[TBL] [Abstract][Full Text] [Related]
17. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome
López-Causapé C; Rubio R; Cabot G; Oliver A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437613
[TBL] [Abstract][Full Text] [Related]
19. [Pseudomonas aeruginosa infection in cystic fibrosis: predominance of a single strain and the influence of antibiotic therapy and the environment].
Michel-Briand Y; Plesiat P; Godard C; Noir A; Estavoyer JM
Bull Acad Natl Med; 1992 Nov; 176(8):1159-69; discussion 1170-1. PubMed ID: 1300222
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Wood DM; Smyth AR
Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
